As a result, cerebrospinal fluid (CSF) and brain regions affected early in AD progression, such as the cortex and hippocampus, indicate that CSF p-tau levels and Aβ PET are pivotal markers for the early detection of AD [40]. The gene discussed is MAPT; the disease is Alzheimer disease.